PharmaSUG2023paper·US·Data Standards
Have Meaningful Relationships: An Example of Implementing SDTM Special Purpose Data Set RELREC with a Many-to-Many Relationship DS-129
Official-source directory
Conference Papers
13,885
available papers
10
available conferences
Papers
Showing 1041–1060 of 3,854
PharmaSUG2023paper·US·Data Standards
ADaM Design and Programming Standardization for Oncology Efficacy Endpoints Based on RECIST 1.1 DS-150
PharmaSUG2023paper·US·Data Standards
Hard Coding: What is it? Why Does It Matter? What Should You Do When Faced With Such A Request? DS-157
PharmaSUG2023paper·US·Data Standards
Handling Anti-Drug Antibody (ADA) Data for Efficient Analysis DS-161
PharmaSUG2023paper·US·Data Standards
Can We Do It Better? Real-Time Validation Of Sdtm Mapping Is Superior To Double Programming DS-193
PharmaSUG2023paper·US·Data Visualization and Reporting
Methods of a Fully Automated CONSORT Diagram Macro %CONSORT DV-024
PharmaSUG2023paper·US·Data Visualization and Reporting
Divergent Nested Bar Plot and SAS Implementation DV-037
PharmaSUG2023paper·US·Data Visualization and Reporting
Ten Rules for Better Charts, Figures and Visuals DV-073
PharmaSUG2023paper·US·Data Visualization and Reporting
Post-surgical opioid pain medications usage evaluation using SAS and Excel DV-116
PharmaSUG2023paper·US·Data Visualization and Reporting
Life Table Analysis for Time to First Event Onset DV-134
PharmaSUG2023paper·US·Data Visualization and Reporting
Amazing Graph Series: Butterfly Graph Using SGPLOT and GTL DV-190
PharmaSUG2023paper·US·Data Visualization and Reporting
The Flexible Ways to Create Graphs for Clinical Trial DV-226
PharmaSUG2023paper·US·Data Visualization and Reporting
Complementary Overlay – A Programmatic Approach to Figure Output Validation DV-256
PharmaSUG2023paper·US·Data Visualization and Reporting
Revolutionizing Statistical Outputs Validation: a Product Demonstration of Verify, an ML-powered Automation Solution Streamlining the Validation Process DV-310
PharmaSUG2023paper·US·FDA Wednesday
OCS Update: OCS Clinical Services & the Traceability Assessment FDA-G002